Azenta (AZTA)
Nasdaq Market Open
Azenta, Inc. is a life sciences technology company that provides sample management, automated storage and genomic services to pharmaceutical, biotechnology, academic and healthcare research customers. The company supports the handling of biological and chemical materials across the research and development cycle, from early discovery work through later-stage commercial and clinical applications.
Azenta’s core expertise is in preserving, organising and analysing high-value samples. Its Sample Management Solutions business supplies automated storage systems, cryogenic and ultra-cold storage technologies, sample tubes, consumables, instruments, thawing devices and related products. These systems help laboratories and research organisations protect the integrity of samples while improving retrieval, tracking and workflow efficiency. This segment represents the company’s largest source of revenue and reflects Azenta’s background in precision automation and cold-chain technologies.
The company also operates a Multiomics business, which provides genomic analysis and related services. These offerings are used by customers seeking insights from DNA, RNA and other biological data, supporting applications such as drug discovery, translational research and broader life sciences development. Azenta’s informatics and repository services complement these capabilities by helping customers store, track and manage complex sample and data collections.
Azenta serves an international customer base, with operations and revenue exposure across the United States, China, the United Kingdom, Europe and other regions. The United States is its largest market. What distinguishes Azenta is its combination of physical sample infrastructure, laboratory automation, consumables and analytical services, positioning the company as an enabling partner for organisations that depend on reliable biological sample preservation and data generation.
Last updated
- Market Cap
- 1.1B
- P/E
- —
- P/FCF
- 36.65
- P/S
- 1.85
- Enterprise Value
- 867.12M
- Sector
- Industrials
- Industry
- Special Industry Machinery, Not Elsewhere Classified
- Address
- 200 SUMMIT DRIVE, BURLINGTON, MA, 01803
Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)
Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. (NASDAQ:AZTA) on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
AZTA SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Azenta, Inc. for Possible Securities Law Violations
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
AZENTA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology
Antibody Production Market to Surpass USD 36.49 Billion by 2032 Driven by Escalating Demand for Targeted Therapies and Technological Advancements | Research by SNS Insider
Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop - Zacks Investment Research
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
3 Stocks to Watch After Impressive Earnings Beats
S&P 500, Nasdaq post best day since April as subdued inflation reading sparks buying frenzy
Azenta (AZTA) Beats Q3 Earnings and Revenue Estimates
Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.1B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 867.12M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.71
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.85
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 23.54
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.45
- EPS
- -3.87
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 36.65
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 17.66
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 30.05M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -11.46%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -9.36%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.08
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.74
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.99
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 1.4M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 23.89
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 144.8M | 148.64M | 158.95M | 143.94M | 143.34M |
| Gross profit | 62.04M | 63.71M | 67.96M | 67.76M | 62.78M |
| Operating income | -165.79M | -7.24M | 1.37M | -714K | -18.19M |
| EBITDA | -1.28M | 7.55M | 15.81M | 14.76M | -661K |
| Net income | -160.8M | -15.43M | 50.84M | -52.81M | -47.66M |
| Basic EPS | -3.49 | -0.34 | 1.11 | -1.15 | -1.04 |
| Diluted EPS | -3.49 | -0.34 | 1.11 | -1.15 | -1.04 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 1.9B | 2.07B | 2.06B | 2.02B | 2.04B |
| Total liabilities | 349.21M | 359.6M | 332.6M | 345.5M | 340.43M |
| Total equity | 1.55B | 1.71B | 1.73B | 1.67B | 1.7B |
| Cash & equivalents | 234.03M | 336.63M | 279.78M | 270.04M | 253.64M |
| Current assets | 724.58M | 777.51M | 705.98M | 676.17M | 708.49M |
| Current liabilities | 235.45M | 243.65M | 223.7M | 230.81M | 224.87M |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | 13.51M | 20.85M | 2.17M | 25.81M | 14.4M |
| Investing cash flow | -114.75M | 36.77M | 826K | -29.7M | -138.67M |
| Financing cash flow | 980K | -2.63M | 817K | -128K | -5.15M |
| Change in cash | -102.7M | 55.3M | 2.87M | 4.95M | -125.57M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| form 4 | Form 4 — Cornog William L | View Filing | |
| form 4 | Form 4 — Starr Ephraim | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | S-8 — Azenta, Inc. | View Filing | |
| edgar index | 10-Q — Azenta, Inc. | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Azenta, Inc. | View Filing | |
| edgar index | 3 — Azenta, Inc. | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — Azenta, Inc. | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4/A — Azenta, Inc. | View Filing | |
| form 4 | Form 4 — Nova Tina Susan | View Filing | |
| edgar index | 10-Q — Azenta, Inc. | View Filing | |
| form 4 | Form 4 — Koffey Quentin | View Filing | |
| form 4 | Form 4 — Koffey Quentin | View Filing | |
| form 4 | Form 4 — Davis Robyn C | View Filing | |
| form 4 | Form 4 — McLaughlin Erica | View Filing | |
| form 4 | Form 4 — Casal Frank | View Filing | |
| form 4 | Form 4 — Doshi Dipal | View Filing | |
| form 4 | Form 4 — Madaus Martin D | View Filing | |
| form 4 | Form 4 — Cornog William L | View Filing | |
| form 4 | Form 4 — Cornog William L | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — Azenta, Inc. | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | ARS — Azenta, Inc. | View Filing | |
| edgar index | DEFR14A — Azenta, Inc. | View Filing | |
| edgar index | DEF 14A — Azenta, Inc. | View Filing | |
| edgar index | DEFA14A — Azenta, Inc. | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — Azenta, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4/A — Azenta, Inc. | View Filing | |
| edgar index | NT 10-K — Azenta, Inc. | View Filing | |
| edgar index | 4/A — Azenta, Inc. | View Filing | |
| edgar index | 4/A — Azenta, Inc. | View Filing | |
| edgar index | 4/A — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing | |
| form 4 | Form 4 — Starr Ephraim | View Filing | |
| form 4 | Form 4 — Zhou Ginger | View Filing | |
| form 4 | Form 4 — Pirogova Olga | View Filing | |
| form 4 | Form 4 — Lin Lawrence Y. | View Filing | |
| form 4 | Form 4 — Marotta John | View Filing | |
| form 4 | Form 4 — Marotta John | View Filing | |
| edgar index | 8-K — Azenta, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Azenta, Inc. | View Filing |